Compatibility: Works synergistically with Vitamin C, Alpha Arbutin, Niacinamide, and Tranexamic Acid for multi-mechanism pigment control
As a class effect shared with GLP-1 receptor agonists, there is a precautionary concern regarding thyroid C-cell tumours, based on animal studies
its a metabolic treatment
The loss of muscle mass is primarily a result of severe calorie deficits and inadequate protein intake, not the medication itself
The most common adverse effects are gastrointestinal , occurring in 20-50% of patients and including nausea, vomiting, diarrhea, constipation, and abdominal pain
On January 12, 2026, Chinas Center for Drug Evaluation (CDE) reached a major milestone by approving Shiling Pharmas Semaglutide Nasal Spray to enter clinical trials for long-term weight management